The pharmaceutical giant manufactures drugs for humans as well as for livestock and poultry.
Looking for leads, investment insights, or competitive intelligence?
News about Eli Lilly
Goldman analysts think the drug could eventually ring in $12 billion in sales if approved.
If he pulls it off, he will make more than all of his peers combined.
In a new letter to Congress